Sebastian Igelmann

1.5k total citations · 1 hit paper
15 papers, 1.0k citations indexed

About

Sebastian Igelmann is a scholar working on Molecular Biology, Physiology and Cancer Research. According to data from OpenAlex, Sebastian Igelmann has authored 15 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 5 papers in Physiology and 5 papers in Cancer Research. Recurrent topics in Sebastian Igelmann's work include RNA modifications and cancer (5 papers), Telomeres, Telomerase, and Senescence (5 papers) and Metabolomics and Mass Spectrometry Studies (2 papers). Sebastian Igelmann is often cited by papers focused on RNA modifications and cancer (5 papers), Telomeres, Telomerase, and Senescence (5 papers) and Metabolomics and Mass Spectrometry Studies (2 papers). Sebastian Igelmann collaborates with scholars based in Canada, Belgium and United States. Sebastian Igelmann's co-authors include Gerardo Ferbeyre, Véronique Bourdeau, Xavier Deschênes‐Simard, Olga Moiseeva, Geneviève Huot, Michaël Pollak, Heidi A. Neubauer, Frédéric Lessard, Mélanie Planque and Ana Margarida Ferreira Campos and has published in prestigious journals such as Nucleic Acids Research, Genes & Development and Nature Cell Biology.

In The Last Decade

Sebastian Igelmann

15 papers receiving 1.0k citations

Hit Papers

Metformin inhibits the senescence‐associated secretory ph... 2013 2026 2017 2021 2013 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Metformin inhibits the senescence‐associated secretory phenotype by interfering with IKK/NF‐κB activation
    2013 486 citations Olga Moiseeva, Xavier Deschênes‐Simard et al. Aging Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sebastian Igelmann Canada 11 567 442 195 178 133 15 1.0k
Geneviève Huot Canada 8 408 0.7× 364 0.8× 155 0.8× 124 0.7× 80 0.6× 8 767
Anja Holtz United States 8 491 0.9× 498 1.1× 223 1.1× 64 0.4× 120 0.9× 17 1.1k
Ana Ortega-Molina Spain 11 629 1.1× 290 0.7× 81 0.4× 156 0.9× 164 1.2× 14 937
Yuanyuan Ling China 6 343 0.6× 529 1.2× 201 1.0× 73 0.4× 71 0.5× 10 872
Husheng Ding United States 12 666 1.2× 767 1.7× 313 1.6× 158 0.9× 145 1.1× 24 1.5k
David Vindrieux France 19 673 1.2× 251 0.6× 213 1.1× 251 1.4× 172 1.3× 35 1.2k
Kelly Gray United Kingdom 12 468 0.8× 236 0.5× 249 1.3× 82 0.5× 182 1.4× 16 1.0k
Hanzhi Luo United States 13 979 1.7× 226 0.5× 224 1.1× 115 0.6× 258 1.9× 18 1.5k
Joshua A. Desotelle United States 12 647 1.1× 439 1.0× 194 1.0× 260 1.5× 169 1.3× 16 1.1k
De‐Long Hao China 19 702 1.2× 302 0.7× 84 0.4× 104 0.6× 221 1.7× 37 1.4k

Countries citing papers authored by Sebastian Igelmann

Since Specialization
Citations

This map shows the geographic impact of Sebastian Igelmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sebastian Igelmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sebastian Igelmann more than expected).

Fields of papers citing papers by Sebastian Igelmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sebastian Igelmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sebastian Igelmann. The network helps show where Sebastian Igelmann may publish in the future.

Co-authorship network of co-authors of Sebastian Igelmann

This figure shows the co-authorship network connecting the top 25 collaborators of Sebastian Igelmann. A scholar is included among the top collaborators of Sebastian Igelmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sebastian Igelmann. Sebastian Igelmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Bourdeau, Véronique, Sebastian Igelmann, Marlene Oeffinger, et al.. (2024). Senescent Macrophages Release Inflammatory Cytokines and RNA-Loaded Extracellular Vesicles to Circumvent Fibroblast Senescence. Biomedicines. 12(5). 1089–1089. 7 indexed citations
2.
Urrutia, Andrés A., H. Furkan Alkan, Inés Soro-Arnáiz, et al.. (2024). HIF1α-dependent uncoupling of glycolysis suppresses tumor cell proliferation. Cell Reports. 43(4). 114103–114103. 10 indexed citations
3.
Deschênes‐Simard, Xavier, Stéphane Lopes‐Paciencia, Benjamin Le Calvé, et al.. (2023). Targeting ribosome biogenesis reinforces ERK-dependent senescence in pancreatic cancer. Cell Cycle. 22(19). 2172–2193. 8 indexed citations
4.
Planque, Mélanie, Sebastian Igelmann, Ana Margarida Ferreira Campos, & Sarah‐Maria Fendt. (2023). Spatial metabolomics principles and application to cancer research. Current Opinion in Chemical Biology. 76. 102362–102362. 47 indexed citations
5.
Parisotto, Maxime, Paloma Kalegari, Sebastian Igelmann, et al.. (2022). The NAMPT Inhibitor FK866 Increases Metformin Sensitivity in Pancreatic Cancer Cells. Cancers. 14(22). 5597–5597. 11 indexed citations
6.
Mascle, Xavier H., Laurent Cappadocia, Véronique Bourdeau, et al.. (2022). Zinc controls PML nuclear body formation through regulation of a paralog specific auto-inhibition in SUMO1. Nucleic Acids Research. 50(14). 8331–8348. 8 indexed citations
7.
Igelmann, Sebastian, Frédéric Lessard, & Gerardo Ferbeyre. (2022). Liquid–Liquid Phase Separation in Cancer Signaling, Metabolism and Anticancer Therapy. Cancers. 14(7). 1830–1830. 14 indexed citations
8.
Lessard, Frédéric, Jordan Guillon, Sebastian Igelmann, et al.. (2021). Cellular senescence limits translational readthrough. Biology Open. 10(12). 2 indexed citations
9.
Deschênes‐Simard, Xavier, Maxime Parisotto, Marie‐Camille Rowell, et al.. (2019). Circumventing senescence is associated with stem cell properties and metformin sensitivity. Aging Cell. 18(2). e12889–e12889. 34 indexed citations
10.
Igelmann, Sebastian, Heidi A. Neubauer, & Gerardo Ferbeyre. (2019). STAT3 and STAT5 Activation in Solid Cancers. Cancers. 11(10). 1428–1428. 81 indexed citations
11.
Ruiz, Ana Fernández, Lian Mignacca, Paloma Kalegari, et al.. (2019). Ribosomal protein RPL22/eL22 regulates the cell cycle by acting as an inhibitor of the CDK4-cyclin D complex. Cell Cycle. 18(6-7). 759–770. 17 indexed citations
12.
Lessard, Frédéric, Sebastian Igelmann, Christian Trahan, et al.. (2018). Senescence-associated ribosome biogenesis defects contributes to cell cycle arrest through the Rb pathway. Nature Cell Biology. 20(7). 789–799. 111 indexed citations
13.
Villiard, Éric, et al.. (2017). Senescence gives insights into the morphogenetic evolution of anamniotes. Biology Open. 6(6). 891–896. 33 indexed citations
14.
Moiseeva, Olga, Xavier Deschênes‐Simard, Sebastian Igelmann, et al.. (2013). Metformin inhibits the senescence‐associated secretory phenotype by interfering with IKK/NF‐κB activation. Aging Cell. 12(3). 489–498. 486 indexed citations breakdown →
15.
Deschênes‐Simard, Xavier, Marie‐France Gaumont‐Leclerc, Véronique Bourdeau, et al.. (2013). Tumor suppressor activity of the ERK/MAPK pathway by promoting selective protein degradation. Genes & Development. 27(8). 900–915. 147 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Geneviève Huot Breakdown of academic impact, for papers by Anja Holtz Breakdown of academic impact, for papers by Ana Ortega-Molina Breakdown of academic impact, for papers by Yuanyuan Ling Breakdown of academic impact, for papers by Husheng Ding Breakdown of academic impact, for papers by David Vindrieux Breakdown of academic impact, for papers by Kelly Gray Breakdown of academic impact, for papers by Hanzhi Luo Breakdown of academic impact, for papers by Joshua A. Desotelle Breakdown of academic impact, for papers by De‐Long Hao
Rankless by CCL
2026